Become a Strategic Site Partner with Catalyst Oncology
Thank you for your interest in Catalyst Oncology’s Early Phase Site Network.
We’re redefining what it means to be part of a site network—moving beyond volume-driven models to build collaborative, trust-based partnerships that accelerate oncology research and improve patient outcomes.
Why Partner with Us?
Catalyst Oncology’s site network is purpose-built for biotech, designed to support early phase oncology trials with precision, speed, and deep therapeutic expertise. We understand the operational pressures clinical sites face and have built a model that eases the burden while enhancing trial performance.
What You Can Expect as a Strategic Partner
- Dedicated Relationship Manager
Personal connections and a single point of contact for streamlined communication.
Flexible workflows that adapt to your site’s unique needs—no one-size-fits-all approach.
Core feasibility, document cloning, and master agreements to reduce negotiation time and accelerate start-up.
Simplified onboarding to reduce site fatigue and expedite activation.
- Slot and Activation Commitments
Prioritization of early slot allocation for the first patient in and subsequent dose levels wherever feasible, to enhance and streamline patient recruitment efforts.
- Early Access to Novel Protocols
First right of review for new studies and investigator engagement opportunities.
- Quarterly Governance Meetings
Transparent collaboration and shared decision-making to strengthen long-term partnerships.
Meet Our Strategic Site Partnership Leadership Team